Literature DB >> 29767787

Sleep-disordered breathing in C57BL/6J mice with diet-induced obesity.

Thomaz Fleury Curado1,2, Huy Pho1, Slava Berger1, Candela Caballero-Eraso1,3, Mi-Kyung Shin1, Luiz Ubirajara Sennes2, Luu Pham1, Alan R Schwartz1, Vsevolod Y Polotsky1.   

Abstract

Obesity leads to sleep-disordered breathing (SDB) manifested by recurrent upper airway obstructions termed obstructive sleep apnea (OSA) and carbon dioxide retention due to hypoventilation. The objective of this work was to characterize breathing during sleep in C57BL6/J mice with diet-induced obesity (DIO). Arterial blood gas was measured in nine obese and nine lean mice during wakefulness. Nine male mice with DIO and six lean male C57BL/6J mice were head mounted with electroencephalogram (EEG) and electromyogram (EMG) electrodes. Sleep recordings were performed in the whole body plethysmography chamber; upper airway obstruction was characterized by the presence of inspiratory flow limitation in which airflow plateaus with increases in inspiratory effort. Obese mice showed significantly lower pH and higher partial pressure of arterial CO2 (PaCO2) in arterial blood gas compared to lean mice, 7.35 ± 0.04 versus 7.46 ± 0.06 (p < 0.001) and 38 ± 8 mm Hg versus 30 ± 5 mm Hg (p < 0.001). Obese mice had similar levels of minute ventilation to lean mice during sleep and wakefulness, despite higher body weight and temperature, indicating an increase in the metabolic rate and hypoventilation. Obese mice also showed baseline hypoxemia with decreased mean oxyhemoglobin saturation across sleep/wake states. Obese mice had a higher prevalence of flow-limited breathing compared to lean mice during sleep. However, the oxygen desaturation index in lean and obese mice did not differ. We conclude that DIO in mice leads to hypoventilation. Obesity also increases the frequency of inspiratory limited breaths, but it does not translate into progression of OSA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29767787      PMCID: PMC6093346          DOI: 10.1093/sleep/zsy089

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  52 in total

1.  Leptin prevents respiratory depression in obesity.

Authors:  C P O'donnell; C D Schaub; A S Haines; D E Berkowitz; C G Tankersley; A R Schwartz; P L Smith
Journal:  Am J Respir Crit Care Med       Date:  1999-05       Impact factor: 21.405

2.  Mechanisms of the respiratory activity of leptin at the level of the solitary tract nucleus.

Authors:  E M Inyushkina; N A Merkulova; A N Inyushkin
Journal:  Neurosci Behav Physiol       Date:  2010-07-16

3.  Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the Pickwick syndrome.

Authors:  H Gastaut; C A Tassinari; B Duron
Journal:  Brain Res       Date:  1966-02       Impact factor: 3.252

4.  Respiratory modulation of the pharyngeal airway in lean and obese mice.

Authors:  Michael J Brennick; Samuel T Kuna; Stephen Pickup; Jacqueline Cater; Richard J Schwab
Journal:  Respir Physiol Neurobiol       Date:  2010-12-16       Impact factor: 1.931

5.  Sleep apnea in obese miniature pigs.

Authors:  R P Lonergan; J C Ware; R L Atkinson; W C Winter; P M Suratt
Journal:  J Appl Physiol (1985)       Date:  1998-02

6.  Ventilatory responses to hypercapnia and hypoxia in patients with eucapnic morbid obesity before and after weight loss.

Authors:  K R Chapman; H S Himal; A S Rebuck
Journal:  Clin Sci (Lond)       Date:  1990-06       Impact factor: 6.124

Review 7.  Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.

Authors:  Luciano F Drager; Sônia M Togeiro; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  J Am Coll Cardiol       Date:  2013-06-12       Impact factor: 24.094

8.  Sleep is increased by weight gain and decreased by weight loss in mice.

Authors:  Zhiwei Guan; Alexandros N Vgontzas; Edward O Bixler; Jidong Fang
Journal:  Sleep       Date:  2008-05       Impact factor: 5.849

9.  Weight loss in mildly to moderately obese patients with obstructive sleep apnea.

Authors:  P L Smith; A R Gold; D A Meyers; E F Haponik; E R Bleecker
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

10.  Upper airway collapsibility in children with obstructive sleep apnea syndrome.

Authors:  C L Marcus; S A McColley; J L Carroll; G M Loughlin; P L Smith; A R Schwartz
Journal:  J Appl Physiol (1985)       Date:  1994-08
View more
  15 in total

1.  High-throughput visual assessment of sleep stages in mice using machine learning.

Authors:  Brian Geuther; Mandy Chen; Raymond J Galante; Owen Han; Jie Lian; Joshy George; Allan I Pack; Vivek Kumar
Journal:  Sleep       Date:  2022-02-14       Impact factor: 5.849

Review 2.  Leptin-mediated neural targets in obesity hypoventilation syndrome.

Authors:  Mateus R Amorim; O Aung; Babak Mokhlesi; Vsevolod Y Polotsky
Journal:  Sleep       Date:  2022-09-08       Impact factor: 6.313

3.  Leptin Induces Hypertension Acting on Transient Receptor Potential Melastatin 7 Channel in the Carotid Body.

Authors:  Mi-Kyung Shin; Candela Caballero Eraso; Yun-Ping Mu; Chenjuan Gu; Bonnie H Y Yeung; Lenise J Kim; Xiao-Ru Liu; Zhi-Juan Wu; Omkar Paudel; Luis E Pichard; Machiko Shirahata; Wan-Yee Tang; James S K Sham; Vsevolod Y Polotsky
Journal:  Circ Res       Date:  2019-09-23       Impact factor: 17.367

4.  Leptin acts in the carotid bodies to increase minute ventilation during wakefulness and sleep and augment the hypoxic ventilatory response.

Authors:  Candela Caballero-Eraso; Mi-Kyung Shin; Huy Pho; Lenise J Kim; Luis E Pichard; Zhi-Juan Wu; Chenjuan Gu; Slava Berger; Luu Pham; Ho-Yee Bonnie Yeung; Machiko Shirahata; Alan R Schwartz; Wan-Yee Winnie Tang; James S K Sham; Vsevolod Y Polotsky
Journal:  J Physiol       Date:  2018-11-29       Impact factor: 5.182

5.  Leptin receptor expression in the dorsomedial hypothalamus stimulates breathing during NREM sleep in db/db mice.

Authors:  Huy Pho; Slava Berger; Carla Freire; Lenise J Kim; Mi-Kyung Shin; Stone R Streeter; Nishitha Hosamane; Meaghan E Cabassa; Frederick Anokye-Danso; Olga Dergacheva; Mateus R Amorim; Thomaz Fleury-Curado; Jonathan C Jun; Alan R Schwartz; Rexford S Ahima; David Mendelowitz; Vsevolod Y Polotsky
Journal:  Sleep       Date:  2021-06-11       Impact factor: 5.849

6.  Pharmacological and Genetic Blockade of Trpm7 in the Carotid Body Treats Obesity-Induced Hypertension.

Authors:  Mi-Kyung Shin; Roxana Mitrut; Chenjuan Gu; Lenise J Kim; Bonnie H Y Yeung; Rachel Lee; Luu Pham; Wan-Yee Tang; James S K Sham; Honggang Cui; Vsevolod Y Polotsky
Journal:  Hypertension       Date:  2021-05-17       Impact factor: 9.897

Review 7.  The Role of Animal Models in Developing Pharmacotherapy for Obstructive Sleep Apnea.

Authors:  Lenise Jihe Kim; Carla Freire; Thomaz Fleury Curado; Jonathan C Jun; Vsevolod Y Polotsky
Journal:  J Clin Med       Date:  2019-11-22       Impact factor: 4.241

8.  Designer Receptors Exclusively Activated by Designer Drugs Approach to Treatment of Sleep-disordered Breathing.

Authors:  Thomaz Fleury Curado; Huy Pho; Carla Freire; Mateus R Amorim; Jordi Bonaventura; Lenise J Kim; Rachel Lee; Meaghan E Cabassa; Stone R Streeter; Luiz G Branco; Luiz U Sennes; Kenneth Fishbein; Richard G Spencer; Alan R Schwartz; Michael J Brennick; Michael Michaelides; David D Fuller; Vsevolod Y Polotsky
Journal:  Am J Respir Crit Care Med       Date:  2021-01-01       Impact factor: 21.405

9.  Silencing of Hypoglossal Motoneurons Leads to Sleep Disordered Breathing in Lean Mice.

Authors:  Thomaz A Fleury Curado; Huy Pho; Olga Dergacheva; Slava Berger; Rachel Lee; Carla Freire; Aya Asherov; Luis U Sennes; David Mendelowitz; Alan R Schwartz; Vsevolod Y Polotsky
Journal:  Front Neurol       Date:  2018-11-14       Impact factor: 4.003

10.  Leptin Receptor Blockade Attenuates Hypertension, but Does Not Affect Ventilatory Response to Hypoxia in a Model of Polygenic Obesity.

Authors:  Lenise J Kim; Mi-Kyung Shin; Huy Pho; Laszlo Otvos; Sergio Tufik; Monica L Andersen; Luu V Pham; Vsevolod Y Polotsky
Journal:  Front Physiol       Date:  2021-07-02       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.